Project Keywords:
Alzheimer’s Detection, Blood Biomarkers, Precision Medicine, Neuroscience, Diagnostics
Project Summary
Academic Area:
Project Medium:
High-Accuracy Blood-Based Dementia Diagnostic System This in-vitro diagnostic technology offers a non-invasive and highly accurate method for detecting Alzheimer’s disease and cognitive decline. Using blood analysis, this system provides over 90% accuracy in identifying biomarkers associated with dementia, enabling early intervention and more personalized treatment plans. Its fast and accessible approach makes it a valuable tool for routine cognitive health screenings.
Project Achievements
Project Inspiration
Project Social Impact
By providing a simple and accessible diagnostic method, this technology allows for earlier detection of cognitive decline, leading to timely intervention and improved patient care. Its non-invasive nature makes it more comfortable for patients, reducing barriers to screening. Widespread adoption of this solution could help identify at-risk individuals earlier, facilitating proactive healthcare strategies and easing the burden on caregivers and healthcare systems.
Project Market Demand
By providing a simple and accessible diagnostic method, this technology allows for earlier detection of cognitive decline, leading to timely intervention and improved patient care. Its non-invasive nature makes it more comfortable for patients, reducing barriers to screening. Widespread adoption of this solution could help identify at-risk individuals earlier, facilitating proactive healthcare strategies and easing the burden on caregivers and healthcare systems.